Stem Cell Driven Clinical Trial For Multiple Sclerosis by Miami Stem Cell | Dec 10, 2021 | regenerative medicine, stem cell therapy AgeX Therapeutics’ Licensee ImStem Biotechnology Does First U.S. Multiple Sclerosis Patient with IMS001
